Top

14-03-2024 | Atrial Fibrillation | Management of Acute Coronary Syndromes (H Jneid, Section Editor)

Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations

Authors: Besher Sadat, Haider Al Taii, Muhie Sabayon, Chockalingam A. Narayanan

Published in: Current Cardiology Reports

Abstract

Purpose of Review

Atrial fibrillation (AF) and myocardial infarction (MI) often coexist, and this overlapping nature leads to heightened morbidity and increases the need for comprehensive risk management strategies. The precise trajectory and implications of atrial fibrillation complicating myocardial infarction remain subjects of debate, with divergent reports presenting varying accounts. This review seeks to provide an in-depth exploration of the existing literature to cover the predictors, implication, and available management of new onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI).

Recent Findings

Clinical risk factors, laboratory markers, echocardiographic findings, and angiographic data can be used to assess patients at risk of developing NOAF post-AMI. The diagnosis of NOAF post MI has been associated with overall worse short- and long-term prognosis with increased risk for mortality, cardiogenic shock, stroke, and bleeding, along with reduced rates of coronary angiography and percutaneous coronary intervention, and higher risk of future recurrence of AF and ischemic stroke.

Summary

Despite the paucity of preventative treatment, the optimal management of acute coronary syndrome and the use of guideline directed therapy do decrease the risk of development of atrial fibrillation post myocardial infarction.

Frederiksen TC, Dahm CC, Preis SR, Lin H, Trinquart L, Benjamin EJ, Kornej J. The bidirectional association between atrial fibrillation and myocardial infarction. Nat Rev Cardiol. 2023;20(9):631–44. https://doi.org/10.1038/s41569-023-00857-3. This study showed the risk of incident AF was higher in patients with MI vs no MI. The risk of incident MI was higher in patients with AF vs no AF. Coexisting AF and MI was associated with higher mortality compared to only MI or AF.CrossRefPubMed

Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, Jouven X. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation. 2011;123(15):1587–93. https://doi.org/10.1161/CIRCULATIONAHA.110.986661.CrossRefPubMedPubMedCentral

Angeli F, Reboldi G, Garofoli M, Ramundo E, Poltronieri C, Mazzotta G, Verdecchia P. Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. Curr Cardiol Rep. 2012;14(5):601–10. https://doi.org/10.1007/s11886-012-0289-3.CrossRefPubMed

Lind L, Sundström J, Ärnlöv J, Ingelsson M, Henry A, Lumbers RT, Lampa E. Life-time covariation of major cardiovascular diseases: A 40-year longitudinal study and genetic studies. Circulation Genomic and Precision Medicine. 2021;14(2): e002963. https://doi.org/10.1161/CIRCGEN.120.002963.CrossRefPubMedPubMedCentral

Axelrod M, Gilutz H, Plakht Y, Greenberg D, Novack L. Early atrial fibrillation during acute myocardial infarction may not be an indication for long-term anticoagulation. Angiology. 2020;71(6):559–66. https://doi.org/10.1177/0003319720908760.CrossRefPubMed

Asanin MR, Vasiljevic ZM, Matic MD, Mrdovic IB, Perunicic JP, Matic DP, Ostojic MC. The long-term risk of stroke in patients with acute myocardial infarction complicated with new-onset atrial fibrillation. Clin Cardiol. 2009;32(8):467–70. https://doi.org/10.1002/clc.20603.CrossRefPubMed

Mori H, Fukui K, Maeda A, Akashi Y, Ako J, Ikari Y, Suzuki H. Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry. J Cardiol. 2022;79(6):768–75. https://doi.org/10.1016/j.jjcc.2022.02.007.CrossRefPubMed

Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Bueno H. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. Eur Heart J Acute Cardiovasc Care. 2019;8(2):121–9. https://doi.org/10.1177/2048872618769057.CrossRefPubMed

• Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, … CREDO-Kyoto AMI Registry Wave-2 Investigators. Newly diagnosed atrial fibrillation in acute myocardial infarction. J Am Heart Assoc. 2021;10(18):e021417. https://doi.org/10.1161/JAHA.121.021417. This study showed newly diagnosed AF increased risk of mortality, HF hospitalization, and major bleeding higher than no AF and comparable to prior AF.

10.

Dai Y, On behalf of the CAMI Registry study group, Yang J, Gao Z, Xu H, Sun Y, … Yang Y. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry. BMC Cardiovasc Disord. 2017;17(1). https://doi.org/10.1186/s12872-016-0442-9

11.

Luo J, Xu S, Li H, Li Z, Liu B, Qin X, … Wei Y. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Failure 2020;7(5):2762–2772. https://doi.org/10.1002/ehf2.12872

12.

McIntyre WF, Um KJ, Cheung CC, Belley-Côté EP, Dingwall O, Devereaux PJ, … Healey JS. Atrial fibrillation detected initially during acute medical illness: A systematic review. Eur Heart J Acute Cardiovasc Care 2019;8(2):130–141. https://doi.org/10.1177/2048872618799748.

13.

McIntyre WF, Vadakken ME, Rai AS, Thach T, Syed W, Um KJ, … Belley-Côté EP. Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis. Journal Canadien d’anesthesie [Can J Anaesth]. 2021;68(7):1045–1056. https://doi.org/10.1007/s12630-021-01944-0.

14.

Obayashi Y, Shiomi H, Morimoto T, Tamaki Y, Inoko M, Yamamoto K, … CREDO-Kyoto AMI Registry Wave-2 Investigators. Newly diagnosed atrial fibrillation in acute myocardial infarction. J Am Heart Associ. 2021;10(18):e021417. https://doi.org/10.1161/JAHA.121.021417.

15.

Jons, C., Jacobsen, U. G., Joergensen, R. M., Olsen, N. T., Dixen, U., Johannessen, A., … Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm: Official J Heart Rhythm Soc. 2011;8(3):342–8. https://doi.org/10.1016/j.hrthm.2010.09.090.

16.

Fauchier L, Bisson A, Bodin A, Herbert J, Angoulvant D, Danchin N, Cottin Y. Outcomes in patients with acute myocardial infarction and new atrial fibrillation: a nationwide analysis. Clinical Research in Cardiology: Official Journal of the German Cardiac Society. 2021;110(9):1431–8. https://doi.org/10.1007/s00392-021-01805-2.CrossRefPubMed

17.

Luo J, Liu B, Li H, Xu S, Gong M, Li Z, … We, Y. Prognostic impact of the symptom of New-onset atrial fibrillation in acute myocardial infarction: Insights from the NOAFCAMI-SH registry. Frontiers in Cardiovascular Medicine 2021;8:677695. https://doi.org/10.3389/fcvm.2021.677695.

18.

Frederiksen, T. C., Trinquart, L., Lin, H., Dahm, C. C., Christiansen, M. K., Jensen, H. K., … Kornej, J. (). Po-05–167 The bidirectional association between atrial fibrillation and myocardial infarction in the Framingham heart study. Heart Rhythm: Official J Heart Rhythm Soc. 2023;20(5):S661–S662. https://doi.org/10.1016/j.hrthm.2023.03.1381.

19.

Romanov A, Martinek M, Pürerfellner H, et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study [published correction appears in Europace. 2017 May 1;19(5):811]. Europace. 2018;20(2):263–270. https://doi.org/10.1093/europace/euw344

20.

Bauer A, Sappler N, von Stülpnagel L, Klemm M, Schreinlechner M, Wenner F, … SMART-MI-DZHK9 investigators. Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial. Lancet Digital Health. 2022;4(2):e105–e116. https://doi.org/10.1016/S2589-7500(21)00253-3

21.

Bloch Thomsen, P. E., Jons, C., Raatikainen, M. J. P., Moerch Joergensen, R., Hartikainen, J., Virtanen, V., … Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. Circulation. 2010;122(13):1258–64. https://doi.org/10.1161/CIRCULATIONAHA.109.902148.CrossRef

22.

Rubenstein JC, Cinquegrani MP, Wright J. Atrial fibrillation in acute coronary syndrome. J Atri Fibrillation. 2012;5(1):551. https://doi.org/10.4022/jafib.551.CrossRef

23.

Skalidis EI, Hamilos MI, Karalis IK, Chlouverakis G, Kochiadakis GE, Vardas PE. Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. J Am Coll Cardiol. 2008;51(21):2053–7. https://doi.org/10.1016/j.jacc.2008.01.055.CrossRefPubMed

24.

Sagnard A, Guenancia C, Mouhat B, Maza M, Fichot M, Moreau D, … Zeller M. Involvement of autonomic nervous system in new-onset atrial fibrillation during acute myocardial infarction. JClin Med. 2020;9(5):1481. https://doi.org/10.3390/jcm9051481.

25.

Karabağ Y, Rencuzogullari I, Çağdaş M, Karakoyun S, Yesin M, Uluganyan M, … Tanboğa Hİ. Association between BNP levels and new-onset atrial fibrillation. Herz. 2018;43(6):548–554. https://doi.org/10.1007/s00059-017-4598-6.

26.

Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J, … Lloyd MS. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol. 2013;112(9):1390–1395. https://doi.org/10.1016/j.amjcard.2013.07.006.

27.

Corban MT, Godo S, Burczak DR, Noseworthy PA, Toya T, Lewis BR, … Lerman A. Coronary endothelial dysfunction is associated with increased risk of incident atrial fibrillation. J Am Heart Assoc. 2020;9(8):e014850. https://doi.org/10.1161/JAHA.119.014850.

28.

Díez-Delhoyo F, Gutiérrez-Ibañes E, Sanz-Ruiz R, Vázquez-Álvarez ME, González Saldívar H, Rivera Juárez A, … Fernández-Avilés F. Prevalence of microvascular and endothelial dysfunction in the nonculprit territory in patients with acute myocardial infarction. Circ Cardiovasc Interv. 2019;12(2):e007257. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007257.

29.

Aronson D, Mutlak D, Bahouth F, Bishara R, Hammerman H, Lessick J, … Agmon Y. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Am J Cardiol. 2011;107(12):1738–1743. https://doi.org/10.1016/j.amjcard.2011.02.334.

30.

Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol. 2005;95(6):764–7. https://doi.org/10.1016/j.amjcard.2004.11.032.CrossRefPubMed

31.

Stacy, M. R., Lin, B. A., Thorn, S. L., Lobb, D. C., Maxfield, M. W., Novack, C., … Spinale, F. G. (2022). Regional heterogeneity in determinants of atrial matrix remodeling and association with atrial fibrillation vulnerability postmyocardial infarction. Heart Rhythm: The Official J Heart Rhythm Soc. 2022;19(5):847–855. https://doi.org/10.1016/j.hrthm.2022.01.022.

32.

Zhang E-Y, Cui L, Li Z-Y, Liu T, Li G-P. High Killips class as a predictor of new-onset atrial fibrillation following acute myocardial infarction: Systematic review and meta-analysis. Chin Med J. 2015;128(14):1964–8. https://doi.org/10.4103/0366-6999.160565.CrossRefPubMedPubMedCentral

33.

Li Y.-G, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, … Fauchier L. C2 HEST score and prediction of incident atrial fibrillation in poststroke patients: A French nationwide study. J Am Heart Assoc. 2019;8(13):e012546. https://doi.org/10.1161/JAHA.119.012546.

34.

Li Y-G, Pastori D, Farcomeni A, Yang P-S, Jang E, Joung B, … Lip GYH. A simple clinical risk score (C2HEST) for predicting incident atrial fibrillation in Asian subjects: Derivation in 471,446 Chinese subjects, with internal validation and external application in 451,199 Korean subjects. Chest. 2019;155(3):510–518. https://doi.org/10.1016/j.chest.2018.09.011.

35.

Ruwald AC, Gang U, Thomsen PEB, Jørgensen RM, Ruwald MH, Huikuri HV, Jons C. The predictive value of CHADS₂ risk score in post myocardial infarction arrhythmias - a Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudy. Int J Cardiol. 2014;173(3):441–6. https://doi.org/10.1016/j.ijcard.2014.03.010.CrossRefPubMed

36.

Biccirè FG, Tanzilli G, Prati F, Sammartini E, Gelfusa M, Celeski M, … Pastori D. Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry. Int J Cardiol. 2023;386:45–49. https://doi.org/10.1016/j.ijcard.2023.05.023. This study showed the C2HEST score may be a valuable tool to identify ACS patients who are at higher risk of new onset atrial fibrillation.

37.

Asanin M, Stankovic S, Mrdovic I, Matic D, Savic L, Majkic-Singh N, … Vasiljevic Z. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Peptides. 2012;35(1):74–77. https://doi.org/10.1016/j.peptides.2012.02.022.

38.

Wang J, Hu S, Liang C, Ling Y. The association between systemic inflammatory response index and new-onset atrial fibrillation in patients with ST-elevated myocardial infarction treated with percutaneous coronary intervention. BMC Cardiovasc Disord. 2022;22(1):525. https://doi.org/10.1186/s12872-022-02989-9.CrossRefPubMedPubMedCentral

39.

Ling Y, Fu C, Fan Q, Liu J, Jiang L, Tang S. Triglyceride-glucose index and new-onset atrial fibrillation in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention. Front Cardiovasc Med. 2022;9:838761. https://doi.org/10.3389/fcvm.2022.838761.CrossRefPubMedPubMedCentral

40.

Lancini D, Prasad A, Thomas L, Atherton J, Martin P, Prasad S. Predicting new onset atrial fibrillation post acute myocardial infarction: Echocardiographic assessment of left atrial size. Echocardiography. 2023;40(6):456–3. https://doi.org/10.1111/echo.15574.CrossRefPubMed

41.

Reinstadler SJ, Stiermaier T, Eitel C, Fuernau G, Saad M, Pöss J, … Eitel I. Impact of atrial fibrillation during ST-segment-elevation myocardial infarction on infarct characteristics and prognosis. Circ Cardiovasc Imaging. 2018;11(2):e006955. https://doi.org/10.1161/CIRCIMAGING.117.006955.

42.

Yildirim E, Ermis E, Allahverdiyev S, Ucar H, Cengiz M. Value of syntax score II in prediction of new-onset atrial fibrillation in patients with NSTE-ACS undergoing percutaneous coronary intervention. Angiology. 2019;70(9):860–6. https://doi.org/10.1177/0003319719854242.CrossRefPubMed

43.

Thomsen AF, Jøns C, Jabbari R, Jacobsen MR, Stampe NK, Butt JH, ... Jacobsen PK. Long-term risk of new-onset arrhythmia in ST-segment elevation myocardial infarction according to revascularization status. EP Europace. 2023;25(3):931–9. https://doi.org/10.1093/europace/euac242.CrossRef

44.

Luo J, Xu S, Li H, Li Z, Liu B, Qin X, Gong M, Shi B, Wei Y. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure. ESC Heart Failure. 2020;7:2762–72. https://doi.org/10.1002/ehf2.12872.CrossRefPubMedPubMedCentral

45.

Guenancia C, Toucas C, Fauchier L, Stamboul K, Garnier F, Mouhat B, ... Cottin Y. High rate of recurrence at long-term follow-up after new-onset atrial fibrillation during acute myocardial infarction. EP Europace. 2018;20(12):e179–88. https://doi.org/10.1093/europace/euy168.CrossRefPubMed

46.

Mohamed MO, Kirchhof P, Vidovich M, Savage M, Rashid M, Kwok CS, … Mamas MA. Effect of concomitant atrial fibrillation on in-hospital outcomes of non-ST-elevation-acute coronary syndrome-related hospitalizations in the United States. Am J Cardiol. 2019;124(4):465–475. https://doi.org/10.1016/j.amjcard.2019.05.040.

47.

Fernandes GC, Kovacs R, Abbott JD, Subacius H, Dyal MD, Goldberger JJ, Outcomes of Beta-Blocker Therapy After Myocardial Infarction (OBTAIN) Investigators. Determinants of early and late in-hospital mortality after acute myocardial infarction: A subanalysis of the OBTAIN registry. Can J Cardiol. 2023;39(4):531–537. https://doi.org/10.1016/j.cjca.2022.10.019.

48.

Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–45. https://doi.org/10.1093/eurheartj/ehn579.CrossRefPubMed

49.

Siu C-W, Jim M-H, Ho H-H, Miu R, Lee SWL, Lau C-P, Tse H-F. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132(1):44–9. https://doi.org/10.1378/chest.06-2733.CrossRefPubMed

50.

Bishara R, Telman G, Bahouth F, Lessick J, Aronson D. Transient atrial fibrillation and risk of stroke after acute myocardial infarction. Thromb Haemost. 2011;106(5):877–84. https://doi.org/10.1160/TH11-05-0343.CrossRefPubMed

51.

Lee JH, Kim S-H, Lee W, Cho Y, Kang S-H, Park JJ, … Choi D-J. New-onset paroxysmal atrial fibrillation in acute myocardial infarction: increased risk of stroke. BMJ Open, 2020;10(9): e039600. https://doi.org/10.1136/bmjopen-2020-039600.

52.

Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119(18):2516–25. https://doi.org/10.1161/CIRCULATIONAHA.108.821306.CrossRefPubMed

53.

Køber L, Swedberg K, McMurray JJV, Pfeffer MA, Velazquez EJ, Diaz R, … Califf RM. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Failure 2006;8(6):591–598. https://doi.org/10.1016/j.ejheart.2005.11.007.

54.

Buchta P, Kalarus Z, Mizia-Stec K, Myrda K, Skrzypek M, Ga Sior M. De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up. Eur Heart J Acute Cardiovasc Care. 2021;10(10):1129–39. https://doi.org/10.1093/ehjacc/zuab091.CrossRefPubMed

55.

Luo J, Xu S, Li H, Gong M, Li Z, Liu B, ... Wei Y. Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry. EP Europace. 2021;23(2):196–204. https://doi.org/10.1093/europace/euaa234.CrossRefPubMed

56.

Stamboul K, Zeller M, Fauchier L, Gudjoncik A, Buffet P, Garnier F, … Cottin Y. Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up. Heart (British Cardiac Soc), 2015;101(11):864–869. https://doi.org/10.1136/heartjnl-2014-307253.

57.

Feistritzer H-J, Desch S, Zeymer U, Fuernau G, de Waha-Thiele S, Dudek D, … Thiele H. Prognostic impact of atrial fibrillation in acute myocardial infarction and Cardiogenic Shock. Cir Cardiovasc Interv. 2019;12(6):e007661. https://doi.org/10.1161/CIRCINTERVENTIONS.118.007661.

58.

de Waha S, Schoene K, Fuernau G, Desch S, Eitel I, Pöss J, … Thiele H. Prognostic impact of atrial fibrillation in cardiogenic shock complicating acute myocardial infarction: a substudy of the IABP-SHOCK II trial. Clin Res Cardiol: Official J German Cardiac Soc. 2018;107(3);233–240. https://doi.org/10.1007/s00392-017-1175-1.

59.

Lopes RD, Elliott LE, White HD, Hochman, JS, Van de Werf F, Ardissino D, … Granger CB. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30(16):2019–2028. https://doi.org/10.1093/eurheartj/ehp213

60.

Rene AG, Généreux P, Ezekowitz M, Kirtane AJ, Xu K, Mehran R, … Stone GW. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2014;113(2):236–242. https://doi.org/10.1016/j.amjcard.2013.09.016.

61.

Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, … Fox KA. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. New Eng J Med. 2016;375(25):2423–2434. https://doi.org/10.1056/nejmoa1611594.

62.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, … Hohnloser SH. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. New Eng J Med. 2017;377(16):1513–1524. https://doi.org/10.1056/nejmoa1708454.

63.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, … AUGUSTUS Investigators. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. New Eng J Med. 2019;380(16):1509–1524.https://doi.org/10.1056/NEJMoa1817083.

64.

Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, … Goette A. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Lancet. 2019;394(10206):1335–1343. https://doi.org/10.1016/S01406736(19)31872-0.

65.

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, … Yancy CW. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125–e151. https://doi.org/10.1161/CIR.0000000000000665.

66.

Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, … Alexander JH. Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: A network meta-analysis of randomized controlled trials. JAMA Cardiol. 2019;4(8):747–755. https://doi.org/10.1001/jamacardio.2019.1880.

67.

Mathews, R., Wang, T. Y., Honeycutt, E., Henry, T. D., Zettler, M., Chang, M., … TRANSLATE-ACS Study Investigators. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J. 2015;170(1):62–9. https://doi.org/10.1016/j.ahj.2015.03.019.CrossRef

68.

De Luca L, Rubboli A, Bolognese L, Uguccioni M, Lucci D, Blengino S, … MATADOR-PCI Investigators. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes? Open Heart. 2021;8(2):e001677. https://doi.org/10.1136/openhrt-2021-001677.

69.

McMurray J, Køber L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, … Ford I. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005;45(4):525–530. https://doi.org/10.1016/j.jacc.2004.09.076.

70.

Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction. Circulation. 1999;100(4):376–80. https://doi.org/10.1161/01.cir.100.4.376.CrossRefPubMed

71.

Wong C-K. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Br Heart J. 2002;88(4):357–62. https://doi.org/10.1136/heart.88.4.357.CrossRef

72.

Nilsson KR Jr, Al-Khatib SM, Zhou Y, Pieper K, White HD, Maggioni AP, … Velazquez EJ. Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart (British Cardiac Soc). 2010;96(11):838–842. https://doi.org/10.1136/hrt.2009.180182.

73.

Danchin N, Fauchier L, Marijon E, Barnay C, Furber A, Mabo P, … French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Investigators. Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register. Heart (British Cardiac Soc), 2010;96(22):1809–1814. https://doi.org/10.1136/hrt.2010.201574.

74.

Bang CN, Gislason GH, Greve AM, Torp-Pedersen C, Køber L, Wachtell K. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Eur J Prev Cardiol. 2014;21(3):330–8. https://doi.org/10.1177/2047487312462804.CrossRefPubMed

75.

Ramani G, Zahid M, Good CB, Macioce A, Sonel AF. Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol. 2007;100(3):404–5. https://doi.org/10.1016/j.amjcard.2007.03.034.CrossRefPubMed

76.

Scirica BM, Belardinelli L, Chaitman BR, Waks JW, Volo S, Karwatowska-Prokopczuk E, ... Morrow DA. Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. EP Europace. 2015;17(1):32–7. https://doi.org/10.1093/europace/euu217.CrossRefPubMed

77.

Kundu A, O’Day K, Shaikh AY, Lessard DM, Saczynski JS, Yarzebski J, … McManus DD. Relation of atrial fibrillation in acute myocardial infarction to in-hospital complications and early hospital readmission. Am J Cardiol. 2016;117(8):1213–1218. https://doi.org/10.1016/j.amjcard.2016.01.012.

78.

Mohamed Ibrahim I, Taha Hassanin M, El Zaki MM. Tissue Doppler-derived atrial dyssynchrony predicts new-onset atrial fibrillation during hospitalization for ST-elevation myocardial infarction. Echocardiography (Mount Kisco, N.Y.) 2019;36(10);1799–1805. https://doi.org/10.1111/echo.14486.

Title: Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations
Authors: Besher Sadat
Haider Al Taii
Muhie Sabayon
Chockalingam A. Narayanan
Publication date: 14-03-2024
Publisher: Springer US
Keywords: Atrial Fibrillation
Myocardial Infarction
Acute Coronary Syndrome
Heart Failure
Stroke
Cardiogenic Shock
Cardiogenic Shock
Biomarkers
Echocardiography
Coronary Heart Disease
Direct Oral Anticoagulant
Fibrinolytic Therapy
Interventional Procedure in Cardiology
Published in: Current Cardiology Reports
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-024-02040-7

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Doctor offering patient support/© Halfpoint / stock.adobe.com (symbolic image with models), ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Atrial Fibrillation Complicating Acute Myocardial Infarction: Prevalence, Impact, and Management Considerations

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page